Bank of Montreal Can reduced its stake in shares of CRH plc (NYSE:CRH – Free Report) by 81.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 397,393 shares of the construction company’s stock after selling 1,731,570 shares during the period. Bank of Montreal Can owned about 0.06% of CRH worth $36,759,000 at the end of the most recent quarter.
Several other hedge funds also recently added to or reduced their stakes in CRH. GHP Investment Advisors Inc. grew its holdings in CRH by 336.4% during the 2nd quarter. GHP Investment Advisors Inc. now owns 336 shares of the construction company’s stock worth $25,000 after acquiring an additional 259 shares in the last quarter. Deseret Mutual Benefit Administrators acquired a new position in CRH during the 3rd quarter worth $25,000. UMB Bank n.a. grew its holdings in CRH by 72.7% during the 3rd quarter. UMB Bank n.a. now owns 297 shares of the construction company’s stock worth $28,000 after acquiring an additional 125 shares in the last quarter. Meeder Asset Management Inc. acquired a new position in shares of CRH in the 3rd quarter valued at about $35,000. Finally, Baillie Gifford & Co. boosted its holdings in shares of CRH by 70.7% in the 3rd quarter. Baillie Gifford & Co. now owns 391 shares of the construction company’s stock valued at $36,000 after buying an additional 162 shares during the period. 62.50% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several research analysts have recently commented on CRH shares. JPMorgan Chase & Co. lifted their price target on shares of CRH from $114.00 to $116.00 and gave the company an “overweight” rating in a report on Wednesday, November 20th. Barclays started coverage on shares of CRH in a report on Tuesday, October 29th. They issued an “overweight” rating and a $110.00 price target for the company. Morgan Stanley lifted their price target on shares of CRH from $95.00 to $104.00 and gave the company an “overweight” rating in a report on Monday, November 11th. StockNews.com raised shares of CRH from a “hold” rating to a “buy” rating in a report on Monday, November 11th. Finally, HSBC initiated coverage on shares of CRH in a report on Monday, November 11th. They issued a “buy” rating and a $116.00 price target for the company. One equities research analyst has rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $106.42.
CRH Trading Down 0.9 %
CRH stock opened at $101.94 on Friday. CRH plc has a 52 week low of $61.51 and a 52 week high of $104.19. The company has a market capitalization of $69.24 billion, a price-to-earnings ratio of 20.39, a price-to-earnings-growth ratio of 1.30 and a beta of 1.29. The firm’s 50-day moving average is $95.18 and its two-hundred day moving average is $86.18.
CRH Cuts Dividend
The business also recently declared a Variable dividend, which will be paid on Wednesday, December 18th. Shareholders of record on Friday, November 22nd will be given a dividend of $0.262 per share. The ex-dividend date of this dividend is Friday, November 22nd. This represents a dividend yield of 1.4%. CRH’s dividend payout ratio (DPR) is 37.20%.
CRH Company Profile
CRH plc, together with its subsidiaries, provides building materials solutions in Ireland and internationally. It operates through four segments: Americas Materials Solutions, Americas Building Solutions, Europe Materials Solutions, and Europe Building Solutions. The company provides solutions for the construction and maintenance of public infrastructure and commercial and residential buildings; and produces and sells aggregates, cement, readymixed concrete, and asphalt, as well as provides paving and construction services.
Featured Stories
- Five stocks we like better than CRH
- P/E Ratio Calculation: How to Assess Stocks
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Want to Profit on the Downtrend? Downtrends, Explained.
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What Are Some of the Best Large-Cap Stocks to Buy?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding CRH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CRH plc (NYSE:CRH – Free Report).
Receive News & Ratings for CRH Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH and related companies with MarketBeat.com's FREE daily email newsletter.